EPISODE · Mar 24, 2025 · 2 MIN
AstraZeneca to invest $2.5 billion in China research and development hub
from Daily SumUp
Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of a recent controversy emerges a multibillion-dollar commitment to China-based research – plus the company’s first vaccine-manufacturing facility in the country.The British-Swedish drug maker, which saw one of its executives detained in China last year, announced a multibillion-dollar investment deal last week, before its CEO attended a global business forum in Beijing.AstraZeneca inked a US$2.5 billion contract with the city government of Beijing to establish the firm’s sixth global strategic R&D centre, with high-end industrialisation projects conducted in the Chinese capital to advance life sciences throughout the country. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of a recent controversy emerges a multibillion-dollar commitment to China-based research – plus the company’s first vaccine-manufacturing facility in the country.The British-Swedish drug maker, which saw one of its executives detained in China last year, announced a multibillion-dollar investment deal last week, before its CEO attended a global business forum in Beijing.AstraZeneca inked a US$2.5 billion contract with the city government of Beijing to establish the firm’s sixth global strategic R&D centre, with high-end industrialisation projects conducted in the Chinese capital to advance life sciences throughout the country. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
AstraZeneca to invest $2.5 billion in China research and development hub
No transcript for this episode yet
Similar Episodes
No similar episodes found.